Just to recap for those who can't listen at work:
1250 plus patients enrolled, study is complete and results are being analyzed now
Mid to late July the results are expected
Submission to FDA de novo class 2 in August
FDA clearance expected before end of calendar year
This part is interesting:
Pricing model is to charge every time the test is used in consultation, they are looking at around 5 to 10 USD each test. They expect at least "in the 10's of millions" of tests to take place in the states alone.
- Forums
- ASX - By Stock
- RAP
- Game On
Game On, page-447
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 307 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online